Regulation News
Financial regulation news from the SEC, FINRA, and government agencies. Track policy changes, enforcement actions, and compliance updates affecting markets.
Nexstar Shares Surge on Political Support for Tegna Acquisition Amid FCC Rule Review
Nexstar Media Group stock jumped 14.3% after former President Trump and FCC Chairman Carr endorsed its Tegna takeover. A Senate hearing on broadcast ownership rules is set for February 10.
Netflix Shares Drop as DOJ Scrutinizes Warner Bros Acquisition
Netflix stock declined over 2% after the Department of Justice issued a civil subpoena related to its proposed Warner Bros deal, raising regulatory uncertainty.
EU Threatens Interim Action Against Meta Over WhatsApp AI Restrictions
Meta shares gained 0.6% despite EU antitrust warnings targeting its limits on rival AI assistants within WhatsApp. The European Commission may impose rare interim measures to preserve competition.
NIO Shares Dip on Major Vehicle Recall Over Software Glitch
NIO shares fell in premarket trading after Chinese regulators ordered a recall of over 246,000 vehicles due to a software issue that can cause in-car screens to black out temporarily.
SSE Shares Approach 52-Week High Amid Regulatory Scrutiny and Investment Focus
SSE shares gained 0.32% to 2,518p in early London trading, nearing a 52-week peak. Investors are monitoring regulatory decisions and the company's £1.8 billion network investment plan.
GSK Nears 52-Week Peak on COPD Drug Approval and U.S. Pricing Developments
GSK shares advanced 0.6% in London trading, approaching a 52-week high following EU approval for Nucala in COPD and amid U.S. drug discount initiatives. Insider trading activity and the upcoming ex-dividend date remain in focus.
South Korean Regulators Eye Stricter Crypto Oversight After Bithumb's $40 Billion Error
South Korea's financial watchdog is pushing for tighter cryptocurrency regulations following a major incident at exchange Bithumb, which mistakenly distributed over $40 billion in Bitcoin to users. Authorities are considering enhanced inspections and addressing systemic vulnerabilities.
Gilead Hits 52-Week Peak on FDA Label Expansion for Yescarta, Earnings in Focus
Gilead Sciences reached a 52-week high after the FDA approved a label update for its Yescarta therapy, expanding use to a rare brain lymphoma. The stock's rally comes ahead of the company's quarterly earnings report.
Disney Shares Face Regulatory Scrutiny as FCC Probes ABC Talk Show
Walt Disney Co's stock will be monitored Monday after U.S. regulators launched an investigation into ABC's 'The View' regarding election airtime rules. Shares closed Friday at $108.70, up 3.6%.
Novo Nordisk Rebounds as FDA Vows Crackdown on Wegovy Copycats
Novo Nordisk B shares surged 5.29% after Hims & Hers halted its $49 compounded version of Wegovy, with the FDA pledging action against unauthorized copycats. The stock remains down roughly 20% over five sessions amid pricing uncertainty.
RTX Dividend Approved Amid Pentagon Scrutiny on Contractor Payouts
RTX declared a $0.68 quarterly dividend payable March 19, while investors monitor a pending Pentagon list that could restrict dividends and buybacks for underperforming defense contractors under a Trump executive order.